Maraviroc Articles
Gilead’s Quad regimen to be HIV market leader in 2020, with over $3 billion sales, says Decision Resources
31 October 2011
ViiV Healthcare withdraws applications of once-daily Celsentri/Selzentry
21 September 2011
Setback for Merck & Co as vicriviroc disappoints in Ph III
22 January 2010
FDA panel OKs Pfizer’s Selzentry for broader us in HIV naive patients, but drug criticized for its cost
12 October 2009
Emergency listing of HIV drugs in Japan
26 January 2009
Pfizer's Selzentry granted full US approval
8 December 2008
EMEA's PDCO thumbs-up to eight PIPs
3 November 2008
US and UK Prix Galien awards 2008, winners announced
6 October 2008
Value of virtual studies of drug-drug interactions
16 June 2008
Selzentry triples number of patients at undetectable HIV
18 February 2008
Pfizer's Celsentri launched in the UK
26 November 2007
Stock Commentary - New York - week to Oct 1, 2007
8 October 2007
Monogram sets up European unit to supply Trofile
8 October 2007
Pfizer's Celsentri gets European Commission approval for patients infected with HIV-1 CCR5-tropic virus
1 October 2007
US FDA approves Pfizer's maraviroc
13 August 2007
Pfizer's maraviroc fares well vs efavirenz
6 August 2007
Pfizer's Celsentri gets CHMP nod
30 July 2007
Pfizer gets "approvable" letter for maraviroc
25 June 2007
Pfizer's maraviroc impresses in HIV trials
12 March 2007
Maraviroc gets priority review in USA and EU
19 February 2007
Pfizer expands patient access to maraviroc
11 December 2006
Studies confirm utility of Monogram's Trofile assay
28 August 2006
UPDATE: Pfizer withdraws support for Altana's lung drug Daxas on mediocre trial results
11 July 2005
Showing 1-28 of 28 articles
- 1
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
